فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
The Ministry of Health and Social Protection announced the launch of a wide-reaching national campaign aimed at regulating and organizing the pharmaceuticals and health products market in Morocco, in an effort to enhance transparency and ensure fair competition among all sector players.
The ministry clarified, in three circulars issued on October 3, that this regulatory campaign targets pharmaceutical establishments, private clinics, and hospitals, following observations of violations involving several entities breaching Law 17-04, known as the “Pharmaceutical and Pharmacy Code.”
The ministry highlighted that recorded violations include selling medicines to clinics at illegal prices and offering unauthorized discounts, free units, or samples, especially those containing narcotic or psychotropic substances. It also issued warnings against any practices restricting pharmaceutical establishments’ participation in tenders or preventing clinics from obtaining medicines at legally fixed prices.
The Ministry of Health stressed the obligation of hospitals and private clinics to comply with several regulatory measures, including invoicing medicines dispensed to patients strictly at the hospitalization price, prohibiting dispensing any medicines or pharmacy products outside therapeutic purposes, and requiring the presence of a pharmacist responsible for inventory under an official agreement with the National Council of Pharmacists.
To ensure strict enforcement of these measures, the ministry, in coordination with the Moroccan Agency for Medicines and Health Products, activated field inspection teams that will conduct detailed inspections inside pharmaceutical institutions and clinics operating without licenses. Pharmacists are also required to track the medicines and health products from manufacturing to dispensing stages, including batch numbers and expiry dates on all sales documents.
The ministry affirmed that any violation of the laws, whether through selling medicines to unlicensed parties or operating in institutions that have lost their licenses, will expose offenders to legal actions and judicial proceedings under Law 17-04 and decree laws regulating toxic substances and combating medical product counterfeiting.
The Ministry of Health and Social Protection concluded by emphasizing that this initiative is part of efforts to enhance health security, protect Moroccan consumers, ensure the availability of medicines at fair legal prices, and create a regulatory environment that encourages responsible investment in the national health sector.
